BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6286732)

  • 1. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.
    Turner GA; Ellis RD; Guthrie D; Latner AL; Monaghan JM; Ross WM; Skillen AW; Wilson RG
    J Clin Pathol; 1982 Aug; 35(8):800-6. PubMed ID: 6286732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide excretion in human malignancies.
    Hunt NH; Smith B; Pembrey R
    Clin Sci (Lond); 1980 Jun; 58(6):463-7. PubMed ID: 6253117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
    Wood PJ; Ross G; Smith CL
    J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
    Gennari C; Francini G; Galli M; Lore F
    J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of adenosine 3',5' cyclic monophosphate and guanosine 3',5' cyclic monophosphate in single urine specimens collected from a large population of healthy subjects.
    Turner GA; Ellis RD; Guthrie D; Latner AL; Skillen AW; Ross WM
    Ann Clin Biochem; 1982 Mar; 19(Pt 2):77-82. PubMed ID: 6280576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary cyclic nucleotides and the cytopathology of human uterine cervical dysplasias.
    Duttagupta C; Romney SL; Palan PR; Slagle NS
    Cancer Res; 1982 Jul; 42(7):2938-43. PubMed ID: 6282452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.
    Criss WE; Murad F
    Cancer Res; 1976 May; 36(5):1714-6. PubMed ID: 178429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of determination of urine cAMP and cGMP in the diagnosis and predicting the therapeutic effect of malignant ovarian tumors].
    Wu XH; Zhang JG
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):162-5, 188. PubMed ID: 1651834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in normal children and those with cystic fibrosis.
    Murad F; Moss WW; Johanson J; Selden RF
    J Clin Endocrinol Metab; 1975 Apr; 40(4):552-9. PubMed ID: 165210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythms in the urinary excretion of cyclic 3',5'-adenosine monophosphate (cyclic AMP) and cyclic 3',5'-guanosine monophosphate (cyclic GMP) in human subjects.
    Kopp L; Lin T; Tucci JR
    J Clin Endocrinol Metab; 1977 Apr; 44(4):673-80. PubMed ID: 191467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cyclic AMP and cyclic GMP in normal and asthmatic subjects during exercise.
    Linklater HA; Strickland KP; Cunningham DA; Griffiths JC; Trevithick JR
    Med Sci Sports; 1979; 11(3):250-5. PubMed ID: 230405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy.
    Kopp L; Paradiz G; Tucci JR
    J Clin Endocrinol Metab; 1977 Mar; 44(3):590-4. PubMed ID: 190264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary levels of cyclic guanosine monophosphate (cGMP) in patients with cancer of the uterine cervix: a valuable prognostic factor of clinical outcome?
    Orbo A; Jaeger R; Sager G
    Eur J Cancer; 1998 Aug; 34(9):1460-2. PubMed ID: 9849432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of cyclic guanosine 3'.5'-monophosphate in children with malignant tumours.
    Puschendorf B; Grunicke H; Jentsch J; Berger H
    J Clin Chem Clin Biochem; 1981 Sep; 19(9):979-81. PubMed ID: 6270232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion and circadian rhythm of cyclic-AMP and cyclic-GMP in childhood.
    Castellote MC; Barberá G; Torralba A
    Rev Esp Fisiol; 1981 Dec; 37(4):403-6. PubMed ID: 6280254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urine cyclic guanosine 3':5'-monophosphate in disseminated cancer.
    Chawla RK; Nixon DW; Shoji M; Rudman D
    Ann Intern Med; 1979 Dec; 91(6):862-4. PubMed ID: 229752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cyclic AMP and cyclic GMP in rats given three different concentrations of cadmium in the diet for one year.
    Machida K; Sugawara K; Ishioka K
    Toxicol Lett; 1983 Apr; 16(1-2):159-64. PubMed ID: 6301107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP in urine to monitor the response to ovarian cancer to therapy.
    Turner GA; Ellis RD; Guthrie D; Latner AL; Ross WM; Skillen AW
    Br J Obstet Gynaecol; 1982 Sep; 89(9):760-4. PubMed ID: 6288064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay for adenosine 3', 5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in human blood, urine, and cerebrospinal fluid.
    Goldberg ML
    Clin Chem; 1977 Mar; 23(3):576-80. PubMed ID: 189955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.
    Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
    Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.